The sale of Horlicks has evinced much media interest because HUL’s foods business has always been a bit of a laggard.
According to reports, GSK is in exclusive talks with Unilever to strengthen its position in India, its most important emerging market.
Coca-Cola is mulling a USD 3.9 billion swoop for Horlicks after GlaxoSmithKline hoisted a 'for sale' sign above the 145-year-old brand," says a report.
GSK Healthcare's flagship products in India include Horlicks and Boost. Its other brands are Eno, Crocin, Iodex and Sensodyne.